PHASE 3 COMMODORE TRIALS OF CROVALIMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): IMPACT ON KIDNEY FUNCTION

  Back

14 Apr 2024 5:45 p.m. 6:45 p.m.

WCN24-AB-828, Poster Board= SUN-293